Insights into therapy: tryptophan oxidation and HIV infection (Q43059416)

13 November 2017

title

Insights into therapy: tryptophan oxidation and HIV infection (English)

1 reference

13 November 2017

Michael F Murray

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

Science Translational Medicine

13 November 2017

published in

1 reference

13 November 2017

1 reference

13 November 2017

1 reference

13 November 2017

page(s)

32ps23

1 reference

Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Induction of pulmonary indoleamine 2,3-dioxygenase by intraperitoneal injection of bacterial lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Clinical relevance of indoleamine 2,3-dioxygenase for alloimmunity and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Tryptophan loading induces oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Epidemiology of potential association between L-tryptophan ingestion and eosinophilia-myalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Rational design of indoleamine 2,3-dioxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active target

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Tryptophan depletion and HIV infection: a metabolic link to pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Increased plasma tryptophan in HIV-infected patients treated with pharmacologic doses of nicotinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3001082

Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease

21 January 2018

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1126/SCITRANSLMED.3000632

Identifiers

DOI

10.1126/SCITRANSLMED.3001082

1 reference

13 November 2017

1 reference